Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2)
Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2) is a research-use monoclonal antibody designed to bind human Her2, also known as ErbB2, CD340 or HER-2/neu. Her2/ErbB2 is a receptor tyrosine kinase and an important oncology research target, particularly in studies of breast cancer, gastric cancer and other Her2-positive tumour models. This antibody is based on the binding specificity of trastuzumab and is intended for laboratory research applications involving Her2/ErbB2 detection, assay development, antibody comparison, biosimilar research and related in vitro studies. It may be useful as a reference-style anti-Her2 antibody in workflows such as ELISA, flow cytometry or other validated immunoassay formats, depending on the user’s own optimisation and experimental conditions. This product is supplied for research use only. It is not intended for therapeutic, diagnostic or clinical use.
Product Specifications
Product Name Alternative
ERBB2, CD340, HER-2/neu, HER2, MLN19, NEU, NGL, TKR1
UniProt
P04626
Reactivity
Human
Target
Her2
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Purification
Purified from cell culture supernatant by affinity chromatography
Dilution
ELISA 1:5000-10000; FC 1:100
Form
Powder
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FC
Host or Source
Human Humanized
Preservative
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization.
Isotype
Human IgG1, kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (DF1485), CF594 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF640R conjugate, 0.1mg/mL
CD31 / PECAM-1 (158-2B3), CF488A conjugate, 0.1mg/mL
